Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy
NCT: NCT07590011 · COMPLETED
Brief Summary
This study aims to evaluate the effects of four-cell galvanic bath therapy on pain and balance in patients with diabetic distal symmetric polyneuropathy. Diabetic peripheral neuropathy is a common complication of diabetes that can lead to pain, sensory loss, and impaired balance. In this randomized controlled study, participants received either conventional rehabilitation alone or conventional rehabilitation combined with four-cell galvanic bath therapy. The intervention was applied over a 4-week period. Pain and balance outcomes were assessed using standardized clinical measures. The findings of this study may help determine the effectiveness of galvanic bath therapy as a supportive treatment option in patients with diabetic neuropathy.
Frequently Asked Questions
What is Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy?
Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy is a clinical trial registered under NCT07590011. Current status: COMPLETED.
What is the status of NCT07590011?
The current status of NCT07590011 (Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy) is: COMPLETED.
When did Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy start?
Effects of Four-Cell Galvanic Therapy on Pain and Balance in Diabetic Peripheral Neuropathy started on 2024-12-24.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.